antineoplastic activity varies sensitive methods individual assessment efficacy needed demonstrate clinical value mr spectroscopy monitoring chemotherapy patient recurrent glioma stereotactic radiotherapy diagnostic imaging chemotherapy included mri proton mr spectroscopy 1h mrs 1h mr spectroscopic imaging 1h si fluorodeoxyglucose fdg tomography pet significant decrease choline signal intensity observed NUMBER months chemotherapy indicating tumour chemosensitivity line tumour shrinkage mri decreased uptake fdg assessment early response mrs help improve treatment protocols patients contrast enhanced single voxel positron emission